×
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Polyp Biopsy Market Share

ID: MRFR/MED/1141-HCR
90 Pages
Kinjoll Dey
October 2025

Polyp Biopsy Market Research Report Information by Type (Colonoscopy, Colposcopy-Directed Biopsy, Esophagogastroduodenoscopy and Laryngoscopy), Distribution Channel (Online Sales Channels, Retail Pharmacies), End User (Hospitals & Clinics, Diagnostic Centres and Academic & Research Organizations) - Forecast till 2035.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Polyp Biopsy Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Market Share

Polyp Biopsy Market Share Analysis

The worldwide market must be strategically positioned to suit consumer and healthcare professional demands to discover and cure polyps. Companies in this specialized market utilize several methods to maintain and develop their gut health market share. New biopsy instruments are a priority for polyposis biopsy companies. Surgery and imaging-guided biopsies are examples of accurate, minimally invasive biopsy procedures. Cutting-edge technology enhances diagnosis accuracy and attracts physicians and nurses seeking new solutions. For market share increase, biopsy equipment must be versatile for diverse body areas and polyps. Offering forceps, brushes, and cleaning gadgets helps companies stand out. This diversity lets physicians and nurses choose the optimal instruments for each patient. Companies work hard to produce patient-friendly testing procedures because they recognize how vital it is. Less discomfort, quicker therapy, and less intrusive treatments make patients pleased. Polyposis biopsy firms that improve the diagnostic procedure portray themselves as patient-centered clinicians. Businesses in the polyposis biopsy sector should expand internationally. Changing products to meet international safety standards, fulfilling regional healthcare requirements, and partnering with global vendors make the market more accessible. Companies become global stars when they reach people worldwide. Companies fund medical education because polyposis diagnosis is so specific. Medical workers learn the latest biopsy procedures via training, courses, and instructional resources. Teaching ensures proper biopsy instrument usage and promotes healthcare professional confidence. Collaborating with gastroenterologists helps achieve market share. Smart companies partner with digestive health physicians and nurses. These agreements simplify product feedback, training program improvement, and medical champion network building. The polyposis biopsy market requires tight regulatory compliance. Companies prioritize regional and international regulations to ensure biopsy product safety and efficacy. Dedicated quality assurance creates confidence between healthcare experts and patients, boosting the company's market reputation. Because medical technology changes, goods must continuously be upgraded. Companies invest in research and development to improve polyposis biopsy instruments' accuracy, usability, and performance. Technologically advanced companies lead their industries. Companies intentionally integrate biopsy equipment to digital health platforms since telemedicine is growing. This allows gastroenterologists and primary care doctors to consult remotely. Telemedicine integrates with healthcare delivery changes and grows market share. Option affordability is crucial for market share growth. Companies that increase manufacturing, negotiate favorable prices, and seek financial help programs raise test product costs. Healthcare personnel that desire cost-effective, high-quality solutions benefit from this approach. Support and follow-up following tests boost market share. Companies that provide aftercare guidance, result interpretation, and follow-up consultations satisfy customers. Happy employees are more likely to recommend the firm to their patients, helping it gain and maintain market share.

Author
Kinjoll Dey
Research Analyst Level I

He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

Get In Touch

Leave a Comment

FAQs

What would be the polyp biopsy market CAGR during the forecast period of 2022 to 2030?

Polyp biopsy market CAGR would be 8.3% during the forecast period.

Who are the players involved in the polyp biopsy market report?

The players in polyp biopsy report areAngiotech, INRAD Inc., Cardinal Health, Inc., Hologic, Inc., Carefusion Corporation, C.R. Bard, Inc., Olympus, Devicor Medical Products Inc., and DTR Medica.

Name the region to lead the polyp biopsy market.

The Americas would lead the polyp biopsy market.

Mention the polyp biopsy market valuation by 2030.

Polyp biopsy market valuation would be USD 2.8 Billion.

Name the distribution channels included in the polyp biopsy market report.

The distribution channels of polyp biopsy market report are online sales channel and retail pharmacies.

Market Summary

The Global Polyp Biopsy Market is projected to grow from 1.58 USD Billion in 2024 to 3.56 USD Billion by 2035, reflecting a robust growth trajectory.

Key Market Trends & Highlights

Polyp Biopsy Market Key Trends and Highlights

  • The market is expected to achieve a compound annual growth rate (CAGR) of 7.68% from 2025 to 2035. By 2035, the market valuation is anticipated to reach 3.56 USD Billion, indicating substantial growth potential. In 2024, the market is valued at 1.58 USD Billion, laying a solid foundation for future expansion. Growing adoption of advanced biopsy technologies due to increasing awareness of colorectal cancer screening is a major market driver.

Market Size & Forecast

2024 Market Size 1.58 (USD Billion)
2035 Market Size 3.56 (USD Billion)
CAGR (2025-2035) 7.68%
Largest Regional Market Share in 2024 latin_america)

Major Players

<p>Cardinal Health, Inc., Angiotech, Carefusion Corporation, R. Bard, Inc., Hologic, Inc., INRAD Inc., NeoDynamics AB, Devicor Medical Products Inc., Olympus, IZI Medical Products, DTR Medica</p>

Market Trends

Polyp Biopsy Market Market Drivers

Market Growth Projections

The Global Polyp Biopsy Market Industry is poised for substantial growth, with projections indicating a market value of 1.58 USD Billion in 2024 and an anticipated increase to 3.56 USD Billion by 2035. This growth trajectory reflects a compound annual growth rate of 7.68% from 2025 to 2035, highlighting the increasing demand for polyp biopsy procedures driven by various factors such as rising colorectal cancer incidence, advancements in biopsy techniques, and government initiatives promoting screening.

Growing Geriatric Population

The aging population worldwide is a crucial factor propelling the Global Polyp Biopsy Market Industry. Older adults are at a higher risk for developing colorectal polyps and cancer, leading to an increased need for screening and biopsy procedures. As the global demographic shifts towards an older population, healthcare systems are likely to see a surge in demand for polyp biopsies. This trend is expected to be reflected in market growth, with projections indicating a rise to 3.56 USD Billion by 2035. The correlation between age and cancer incidence underscores the importance of addressing this demographic shift in the context of market expansion.

Advancements in Biopsy Techniques

Technological innovations in biopsy techniques are significantly influencing the Global Polyp Biopsy Market Industry. Enhanced imaging technologies, such as high-definition endoscopy and virtual colonoscopy, improve the accuracy of polyp detection and characterization. These advancements not only facilitate earlier diagnosis but also increase the efficiency of biopsy procedures. As healthcare providers adopt these cutting-edge technologies, the demand for polyp biopsies is likely to surge. This shift towards more sophisticated diagnostic methods aligns with the industry's growth trajectory, as evidenced by the anticipated market expansion to 3.56 USD Billion by 2035.

Increased Awareness and Education

Heightened awareness and education regarding colorectal health are driving factors in the Global Polyp Biopsy Market Industry. Campaigns aimed at educating the public about the risks of colorectal cancer and the importance of early detection have led to increased screening rates. As individuals become more informed about the benefits of polyp biopsies, they are more likely to seek these procedures. This growing awareness is anticipated to contribute to the market's expansion, with estimates suggesting a market value of 1.58 USD Billion in 2024, potentially reaching 3.56 USD Billion by 2035.

Rising Incidence of Colorectal Cancer

The increasing prevalence of colorectal cancer globally is a primary driver for the Global Polyp Biopsy Market Industry. As awareness of the disease rises, more individuals undergo screening procedures, leading to a higher demand for polyp biopsies. According to health statistics, colorectal cancer remains one of the leading causes of cancer-related deaths worldwide. This trend is expected to contribute to the market's growth, with projections indicating that the market will reach 1.58 USD Billion in 2024 and potentially expand to 3.56 USD Billion by 2035, reflecting a compound annual growth rate of 7.68% from 2025 to 2035.

Government Initiatives and Screening Programs

Government initiatives aimed at promoting cancer screening are pivotal in shaping the Global Polyp Biopsy Market Industry. Many countries have implemented national screening programs that encourage early detection of colorectal cancer. These programs often include recommendations for regular colonoscopies, which inherently involve polyp biopsies. As a result, the number of individuals undergoing these procedures is expected to rise, thereby driving market growth. The proactive stance taken by health authorities not only raises awareness but also enhances accessibility to screening services, contributing to the projected market value of 1.58 USD Billion in 2024.

Market Segment Insights

Regional Insights

Key Companies in the Polyp Biopsy Market market include

Industry Developments

IZI Medical Products, LLC, a major developer of medical devices used in interventional radiology and interventional oncology treatments, has launched the Quick-Core Auto Biopsy Systems for polyp biopsy. The Quick-Core Auto is a portable, fully automatic biopsy devices that enhances the dependability, precision, and quality of IZI's semi-automatic Quick-Core biopsy system.

NeoDynamics AB, a MedTech company focused to improve breast cancer diagnosis and treatment, has announced a collaboration with the Buckinghamshire Healthcare NHS Trust in London for their NeoNavia pulse biopsy device.

 

Future Outlook

Polyp Biopsy Market Future Outlook

<p>The Polyp Biopsy Market is poised for growth at 7.68% CAGR from 2024 to 2035, driven by technological advancements, increasing prevalence of colorectal cancer, and rising awareness of preventive healthcare.</p>

New opportunities lie in:

  • <p>Develop innovative biopsy devices integrating AI for enhanced diagnostic accuracy. Expand telehealth services for remote consultations and follow-ups in polyp management. Invest in educational programs to raise awareness about the importance of regular screenings.</p>

<p>By 2035, the Polyp Biopsy Market is expected to achieve substantial growth, reflecting advancements and increased healthcare engagement.</p>

Market Segmentation

Report Scope

Attribute/MetricDetails
Market Size 2022N/A (USD Billion)
Market Size 2023N/A (USD Billion)
Market Size 20322.8 (USD Billion)
Compound Annual Growth Rate (CAGR)8.3 % (2024- 2032)
Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year2022
Market Forecast Period2023 - 2032
Historical Data2019 - 2022
  Geographies Covered  North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors  Cardinal Health, Inc., Angiotech, Carefusion Corporation, C.R. Bard, Inc., Hologic, Inc., INRAD Inc., Devicor Medical Products Inc., Olympus, and DTR Medica
  Key Market Opportunities  Growing geriatric populations, and increasing prevalence of colorectal cancer are projected to drive the market growth.
  Key Market Drivers  On the other hand, uncertain regulatory issues and biopsy-related risk of infections are expected to restrict the market growth during the forecast period.

FAQs

What would be the polyp biopsy market CAGR during the forecast period of 2022 to 2030?

Polyp biopsy market CAGR would be 8.3% during the forecast period.

Who are the players involved in the polyp biopsy market report?

The players in polyp biopsy report areAngiotech, INRAD Inc., Cardinal Health, Inc., Hologic, Inc., Carefusion Corporation, C.R. Bard, Inc., Olympus, Devicor Medical Products Inc., and DTR Medica.

Name the region to lead the polyp biopsy market.

The Americas would lead the polyp biopsy market.

Mention the polyp biopsy market valuation by 2030.

Polyp biopsy market valuation would be USD 2.8 Billion.

Name the distribution channels included in the polyp biopsy market report.

The distribution channels of polyp biopsy market report are online sales channel and retail pharmacies.

  1. Definition
    1. Scope of the Study
      1. Research Objective
      2. Assumptions
      3. Limitations
    2. Overview
    3. Primary Research
    4. Secondary Research
    5. Market Size Estimation
    6. Drivers
    7. Restraints
    8. Opportunities
    9. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
    10. Value Chain Analysis
      1. R&D and Designing
      2. Manufacturing
      3. Distribution & Sales
      4. Post-Sales Review
  2. Chapter 6. Global Polyp Biopsy Market, by Type
    1. Overview
    2. Colonoscopy
  3. Market Estimates & Forecast, by Region, 2020-2027
  4. Market Estimates & Forecast, by Country, 2020-2027
    1. Colposcopy-Directed Biopsy
  5. Market Estimates & Forecast, by Region, 2020-2027
  6. Market Estimates & Forecast, by Country, 2020-2027
    1. Esophagogastroduodenoscopy
  7. Market Estimates & Forecast, by Region, 2020-2027
  8. Market Estimates & Forecast, by Country, 2020-2027
    1. Laryngoscopy
  9. Market Estimates & Forecast, by Region, 2020-2027
  10. Market Estimates & Forecast, by Country, 2020-2027
    1.  
  11. Chapter 7. Global Polyp Biopsy Market, by Distribution Channel
    1. Overview
    2. Online Sales Channels
  12. Market Estimates & Forecast, by Region, 2020-2027
  13. Market Estimates & Forecast, by Country, 2020-2027
    1. Retail Pharmacies
  14. Market Estimates & Forecast, by Region, 2020-2027
  15. Market Estimates & Forecast, by Country, 2020-2027
  16. Chapter 8. Global Polyp Biopsy Market, by End User
    1. Overview
    2. Hospitals & Clinics
  17. Market Estimates & Forecast, by Region, 2020-2027
  18. Market Estimates & Forecast, by Country, 2020-2027
    1. Diagnostic Centers
  19. Market Estimates & Forecast, by Region, 2020-2027
  20. Market Estimates & Forecast, by Country, 2020-2027
    1. Academic & Research Organizations
  21. Market Estimates & Forecast, by Region, 2020-2027
  22. Market Estimates & Forecast, by Country, 2020-2027
    1.  
  23. Chapter 10. Global Polyp Biopsy Market, by Region
    1. Overview
    2. Americas
      1. North America
      2. Latin America
    3. Europe
      1. Western Europe
      2. Eastern Europe
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
      4. Australia
      5. South Korea
      6. Rest of Asia-Pacific
    5. Middle East & Africa
      1. Middle East
      2. Africa
    6. Chapter 11. Company Landscape
    7. Overview
    8. Competitive Analysis
    9. Chapter 12. Company Profile
    10. Angiotech
      1. Company Overview
      2. Products/Services Offered
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
      6. Key Strategies
    11. Cardinal Health, Inc.
      1. Company Overview
      2. Products/Services Offered
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
      6. Key Strategies
    12. Carefusion Corporation
      1. Company Overview
      2. Products/Services Offered
      3. Financial Overview
      4. Key Development
      5. SWOT Analysis
      6. Key Strategies
    13. C.R. Bard, Inc.
      1. Company Overview
      2. Products/Services Offered
      3. Financial Overview
      4. Key Development
      5. SWOT Analysis
      6. Key Strategies
    14. Devicor Medical Products Inc.
      1. Company Overview
      2. Products/Services Offered
      3. Financial overview
      4. Key Developments
      5. SWOT Analysis
      6. Key Strategies
    15. DTR Medical
      1. Company Overview
      2. Products/Services Offered
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
      6. Key Strategies
    16. Hologic, Inc.
      1. Overview
      2. Products/Services Offered
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
      6. Key Strategies
    17. INRAD Inc.
      1. Overview
      2. Products/Services Offered
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
      6. Key Strategies
    18. Olympus
      1. Overview
      2. Products/Services Offered
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
      6. Key Strategies
    19. Others
    20. Chapter 13 Appendix
    21. References
    22. Related Reports
    23.  
  24. LIST OF TABLES
  25. Global Polyp Biopsy Market Synopsis, 2020-2027
  26. Global Polyp Biopsy Market Estimates and Forecast, 2020-2027 (USD Million)
  27. Global Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
  28. Global Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
  29. Global Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
  30. Global Polyp Biopsy Market, by Region, 2020-2027 (USD Million)
  31. Americas: Polyp Biopsy Market, by Region, 2020 and 2025
  32. Americas: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
  33. Americas: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
  34. Americas Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
  35. North America: Polyp Biopsy Market, by Country, 2020-2027 (USD Million)
  36. North America: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
  37. North America: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
  38. North Americas Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
  39. US: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
  40. US: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
  41. US: Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
  42. Canada: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
  43. Canada: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
  44. Canada: Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
  45. Latin America: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
  46. Latin America: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
  47. Latin America: Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
  48. Europe: Polyp Biopsy Market, by Region, 2020-2027 (USD Million)
  49. Europe: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
  50. Europe: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
  51. Europe: Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
  52. Western Europe: Polyp Biopsy Market, by Country, 2020-2027 (USD Million)
  53. Western Europe: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
  54. Western Europe: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
  55. Western Europe: Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
  56. Eastern Europe: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
  57. Eastern Europe: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
  58. Eastern Europe: Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
  59. Asia-Pacific: Polyp Biopsy Market, by Country, 2020-2027 (USD Million)
  60. Asia-Pacific: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
  61. Asia-Pacific: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
  62. Asia-Pacific: Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
  63. Middle East & Africa: Polyp Biopsy Market, by Region, 2020-2027 (USD Million)
  64. Middle East & Africa: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
  65. Middle East & Africa: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
  66. Middle East & Africa: Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
    1.  
  67. LIST OF FIGURES
  68. Research Process
  69. Market Structure for Global Polyp Biopsy Market
  70. Market Dynamics for Global Polyp Biopsy Market
  71. Global Polyp Biopsy Market Share, by Type, 2020 (%)
  72. Global Polyp Biopsy Market Share, by Type, 2020 (USD Million)
  73. Global Polyp Biopsy Market Share, by Distribution Channel, 2020 (%)
  74. Global Polyp Biopsy Market Share, by Distribution Channel, 2020 (USD Million)
  75. Global Polyp Biopsy Market Share, by End User, 2020 (%)
  76. Global Polyp Biopsy Market Share, by End User, 2020 (USD Million)
  77. Global Polyp Biopsy Market Share, by Region, 2020 (%)
  78. Americas: Polyp Biopsy Market Share, by Region, 2020 (%)
  79. North America: Polyp Biopsy Market Share, by Country, 2020 (%)
  80. Europe: Polyp Biopsy Market Share, by Region, 2020 (%)
  81. Asia-Pacific: Polyp Biopsy Market Share, by Country, 2020 (%)
  82. Middle East & Africa: Polyp Biopsy Market Share, by Region, 2020 (%)
  83. Global Polyp Biopsy Market: Company Share Analysis, 2020 (%)
  84. Angiotech: Key Financials
  85. Angiotech: Segmental Revenue
  86. Angiotech: Regional Revenue
  87. Cardinal Health, Inc.: Key Financials
  88. Cardinal Health, Inc.: Segmental Revenue
  89. Cardinal Health, Inc.: Regional Revenue
  90. Carefusion Corporation: Key Financials
  91. Carefusion Corporation: Segmental Revenue
  92. Carefusion Corporation: Regional Revenue
  93. C.R. Bard, Inc.: Key Financials
  94. C.R. Bard, Inc.: Segmental Revenue
  95. C.R. Bard, Inc.: Regional Revenue
  96. Devicor Medical Products Inc.: Key Financials
  97. Devicor Medical Products Inc.: Segmental Revenue
  98. Devicor Medical Products Inc.: Regional Revenue
  99. DTR Medical: Key Financials
  100. DTR Medical: Segmental Revenue
  101. DTR Medical: Regional Revenue
  102. Hologic, Inc.: Key Financials
  103. Hologic, Inc.: Segmental Revenue
  104. Hologic, Inc.: Regional Revenue
  105. INRAD Inc.: Key Financials
  106. INRAD Inc.: Segmental Revenue
  107. INRAD Inc.: Regional Revenue
  108. Olympus: Key Financials
  109. Olympus: Segmental Revenue
  110. Olympus: Regional Revenue

Polyp Biopsy Market Segmentation

Market Segmentation Overview

  • Detailed segmentation data will be available in the full report
  • Comprehensive analysis by multiple parameters
  • Regional and country-level breakdowns
  • Market size forecasts by segment
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne

Founder
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓